| Literature DB >> 36005658 |
Yu-Jing Liu1, Yan-Nan Lu1, Dong-Qing Liang1,2, Yin-Shuang Hu1,2, Yu-Xi Huang1,2.
Abstract
Membrane distillation (MD) has emerged as a promising technology for hypersaline wastewater treatment. However, membrane scaling is still a critical issue for common hydrophobic MD membranes. Herein, we report a multi-layered surface modification strategy on the commercial polyvinylidene fluoride (PVDF) membrane via plasma treatment and surface fluorination cycles. The repeated plasma treatment process generates more reaction sites for the fluorination reaction, leading to higher fluorination density and more branched structures. MD tests with CaSO4 as the scaling agent show that the modification strategy mentioned above improves the membrane scaling resistance. Notably, the PVDF membrane treated with three cycles of plasma and fluorination treatments exhibits the best anti-scaling performance while maintaining almost the same membrane flux as the unmodified PVDF membrane. This study suggests that a highly branched surface molecular structure with low surface energy benefits the MD process in both membrane flux and scaling resistance. Besides, our research demonstrates a universal and facile approach for membrane treatment to improve membrane scaling resistance.Entities:
Keywords: membrane distillation; multi-layered surface modification; scaling resistance; superhydrophobic membrane
Year: 2022 PMID: 36005658 PMCID: PMC9416731 DOI: 10.3390/membranes12080743
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Figure 1The procedure of repeated plasma-CVD modification strategies. (A) Modification process with multiple CVD steps and (B) modification process with multiple plasma-CVD cycles.
The element ratio of different CVD and plasma treatment times modified membranes.
| Membrane Types | C/% | O/% | F/% | Si/% |
|---|---|---|---|---|
| Pristine | 41.1 | 1.72 | 57.18 | 0 |
| CVD-1/P-1 | 47.55 | 1.3 | 51.09 | 0.05 |
| CVD-2 | 39.16 | 2.11 | 58.63 | 0.1 |
| CVD-3 | 47.10 | 1.86 | 51.00 | 0.04 |
| P-2 | 46.13 | 1.85 | 51.98 | 0.03 |
| P-3 | 45.52 | 2.51 | 51.82 | 0.15 |
Figure 2XPS spectra of C 1s binding energy of the pristine and modified membranes.
The membrane characterization of different CVD and plasma treatment times for modified membranes.
| Membrane | Pore Size | Water Contact Angle | Porosity | Bubble Point |
|---|---|---|---|---|
| Pristine | 0.28 ± 0.009 | 131.1 ± 1.3 | 59.51 ± 2.65 | 0.426 |
| CVD-1/P-1 | 0.43 ± 0.025 | 140.4 ± 1.1 | 77.77 ± 1.64 | 0.447 |
| CVD-2 | 0.32 ± 0.023 | 142.2 ± 1.1 | 75.72 ± 3.57 | 0.440 |
| CVD-3 | 0.30 ± 0.008 | 141.1 ± 1.7 | 78.97 ± 4.64 | 0.422 |
| P-2 | 0.42 ± 0.009 | 142.4 ± 2.1 | 70.79 ± 3.07 | 0.444 |
| P-3 | 0.29 ± 0.009 | 149.5 ± 1.3 | 73.39 ± 1.95 | 0.340 |
Figure 3The MD performance of different modified times of (A) CVD and (B) P-C treatment (feed solution: 35 g·L−1 NaCl).
Figure 4The MD performance of different modified times of (A) CVD and (B) P-C treatment (feed solution: 20 mM mixture of CaCl2 and Na2SO4). Initial flux, Pristine: 16 kg·m−2 h−1; CVD-1/P-1: 11 kg·m−2 h−1; CVD-2: 12 kg·m−2 h−1; CVD-3: 10 kg·m−2 h−1; P-2: 13 kg·m−2 h−1; P-3: 15 kg·m−2 h−1.
The scale mass on the membrane surface after scaling tests.
| Membrane Types | Pristine | CVD-1/P-1 | CVD-2 | CVD-3 | P-2 | P-3 |
|---|---|---|---|---|---|---|
| Scale Mass/g | 0.1792 | 0.0244 | 0.0160 | 0.0048 | 0.0056 | 0.0058 |
Figure 5The cross-section of SEM and elemental mapping images of (A) pristine, (B) CVD-1, (C) CVD-2, and (D) CVD-3.
Figure 6The cross-section of SEM and elemental mapping images of (A) pristine, (B) P-1, (C) P-2, and (D) P-3.